RE:RE:Possible JV or take over?? Read thisRead this below, it is mentioned in the report. Saliva test will dominate the market. Something is going on and it seems THRM is under pressure and will do a JV or be a subject of a takeover. The only thing is, we don't know at what price.
The MicroGEM Sal6830 SARS-CoV-2 Saliva Test has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use at the point of care in patient settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. MicroGEM is seeking full FDA approval.